Market closedNon-fractional
Asensus Surgical/ASXC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Asensus Surgical
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Ticker
ASXC
Sector
Healthcare
Trading on
AMEX
Industry
Health Care Equipment and Supplies
Headquarters
Durham, United States
Employees
208
Website
www.asensus.com
Asensus Surgical Metrics
BasicAdvanced
$92M
Market cap
-
P/E ratio
-$0.31
EPS
1.43
Beta
-
Dividend rate
Price and volume
Market cap
$92M
Beta
1.43
Financial strength
Current ratio
0.998
Quick ratio
0.449
Long term debt to equity
33.784
Total debt to equity
41.892
Management effectiveness
Return on assets (TTM)
-67.39%
Return on equity (TTM)
-169.75%
Valuation
Price to revenue (TTM)
9.956
Price to book
7.04
Price to tangible book (TTM)
7.69
Price to free cash flow (TTM)
-1.427
Growth
Revenue change (TTM)
24.68%
Earnings per share change (TTM)
-7.83%
3-year revenue growth (CAGR)
23.26%
3-year earnings per share growth (CAGR)
-16.52%
What the Analysts think about Asensus Surgical
Analyst Ratings
Majority rating from 2 analysts.
Asensus Surgical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1M
-79.63%
Net income
-$22M
30.23%
Profit margin
-2,036.36%
539.34%
Asensus Surgical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.09
-$0.07
-$0.06
-$0.08
-
Expected
-$0.08
-$0.07
-$0.08
-$0.05
-$0.06
Surprise
12.50%
0.00%
-25.00%
60.00%
-
Asensus Surgical News
AllArticlesVideos
Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program
GlobeNewsWire·3 days ago
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology
GlobeNewsWire·4 days ago
Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Asensus Surgical stock?
Asensus Surgical (ASXC) has a market cap of $92M as of July 27, 2024.
What is the P/E ratio for Asensus Surgical stock?
The price to earnings (P/E) ratio for Asensus Surgical (ASXC) stock is 0 as of July 27, 2024.
Does Asensus Surgical stock pay dividends?
No, Asensus Surgical (ASXC) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Asensus Surgical dividend payment date?
Asensus Surgical (ASXC) stock does not pay dividends to its shareholders.
What is the beta indicator for Asensus Surgical?
Asensus Surgical (ASXC) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Asensus Surgical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.